Loading
MP
Mantra Pharma Inc. Stock: price and insider trades · Canada
Mantra Pharma Inc.: what insiders have been doing
Mantra Pharma Inc. is a listed company. Filings by its managers are published through SEDI. From 18 October 2025 to 18 October 2026, the disclosure feed for Mantra Pharma Inc. logged 3 filings by 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Across the 2,144 companies tracked on its exchange, the median is 12 filings; at 3 filings, this issuer sits below that mark.
No insider has bought Mantra Pharma Inc. shares on the open market in the past twelve months. Half of the filings or more reach the SEDI feed on the day of the trade. Until a filing is published, the market cannot know about the trade.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 24 September 2026
Declarations3 total
200,000 shares@ CA$0.05100.0% of flowWarrantsTSXSEDI:4781346
200,000 sharesWarrantsTSXSEDI:4781239
200,000 shares@ CA$0.05100.0% of flowWarrantsTSXSEDI:4781206
3 of 3 declarations
About Mantra Pharma Inc.
Mantra Pharma Inc. is a pharmaceutical company focused on developing innovative treatments. It is listed on the Toronto Stock Exchange under the symbol XTSE.
